Inna Ermilova

Inna Ermilova

Auto-generated profile, based on publicly available information

Inna Ermilova

Chalmers University of Technology

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2018 in Soft Matter
Verified
Journal Article
Open access
PDF file
IEInna Ermilova
Inna Ermilova
ALAlexander Lyubartsev
Alexander Lyubartsev
Cholesterol is an essential component of all animal cell membranes and plays an important role in maintaining the membrane structure and physical–chemical properties necessary for correct cell functioning.

9 December 2020 in Physical Chemistry Chemical Physics
Verified
Journal Article
Open access
PDF file
IEInna Ermilova
Inna Ermilova
JSJan Swenson
Jan Swenson
A comparison of behavior of DOPC and DOPE lipids in the shell of lipid nano-particles.

14 December 2016 in The Journal of Physical Chemistry B
Verified
Journal Article
Closed access
IEInna Ermilova
Inna Ermilova
ALAlexander Lyubartsev
Alexander Lyubartsev

31 July 2023 in Physical Chemistry Chemical Physics
Verified
Journal Article
Open access
PDF file
KAKajsa Ahlgren
Kajsa Ahlgren
COChristoffer Olsson
Christoffer Olsson
IEInna Ermilova
Inna Ermilova
JSJan Swenson
Jan Swenson
3D visualization of the water covered myoglobin surface in the trehalose system. The white stick figures are trehalose molecules located outside the protein hydration layer.

26 October 2019 in European Biophysics Journal
Verified
Journal Article
Open access
PDF file
NNNikolaos Ntarakas
Nikolaos Ntarakas
IEInna Ermilova
Inna Ermilova
ALAlexander Lyubartsev
Alexander Lyubartsev
Aggregation of amyloid- $$\beta $$β (Aβ) peptides, cleaved from the amyloid precursor protein, is known as a precursor of the Alzheimer’s disease (AD). It is also known that Alzheimer’s disease is characterized by a substantial decrease of the amount of polyunsaturated lipids in the neuronal membranes of the frontal gray matter. To get insight into possible interconnection of these phenomena, we have carried out molecular dynamics simulations of two fragments of A $$\beta $$β peptide, A $$\beta $$β $$_{1-28}$$1-28 and A $$\beta $$β $$_{26-40}$$26-40 , in four different lipid bilayers: two monocomponent ones (14:0-14:0 PC, 18:0-22:6 PC), and two bilayers containing mixtures of 18:0-18:0 PE, 22:6-22:6 PE, 16:0-16:0 PC and 18:1-18:1 PC lipids of composition mimicking neuronal membranes in a “healthy” and “AD” brain. The simulations showed that the presence of lipids with highly unsaturated 22:6cis fatty acids chains strongly affects the interaction of amyloid- $$\beta $$β peptides with lipid membranes. The polyunsaturated lipids cause stronger adsorption of A $$\beta $$β -peptides by the membrane and lead to weaker binding between peptides when the latter form aggregates. This difference in the behaviour observed in monocomponent bilayers is propagated in a similar fashion to the mixed membranes mimicking composition of neuronal membranes in “healthy” and “AD” brains, with “healthy” membrane having higher fraction of polyunsaturated lipids. Our simulations give strong indication that it can be physical–chemical background of the interconnection between amyloid fibrillization causing Alzheimer’s disease, and content of polyunsaturated lipids in the neuronal membranes.

5 February 2021 in ACS Chemical Neuroscience
Verified
Journal Article
Open access
WCWojciech Chrobak
Wojciech Chrobak
DPDawid Wojciech Pacut
Dawid Wojciech Pacut
FBFredrik Blomgren
Fredrik Blomgren
ARAlexander Rodin
Alexander Rodin
JSJan Swenson
Jan Swenson
IEInna Ermilova
Inna Ermilova
In this work cannabidiol (CBD) was investigated as a possible drug against the cytotoxicity of Aβ(31–35) and Aβ(25–35) peptides with the help of atomistic molecular dynamics (MD) and well-tempered metadynamics simulations. Four interrelated mechanisms of possible actions of CBD are proposed from our computations. This implies that one mechanism can be a cause or/and a consequence of another. CBD is able to decrease the aggregation of peptides at certain concentrations of compounds in water. This particular action is more prominent for Aβ(25–35), since originally Aβ(31–35) did not exhibit aggregation properties in aqueous solutions. Interactions of CBD with the peptides affect secondary structures of the latter ones. Clusters of CBD are seen as possible adsorbents of Aβ(31–35) and Aβ(25–35) since peptides are tending to aggregate around them. And last but not least, CBD exhibits binding to MET35. All four mechanisms of actions can possibly inhibit the Aβ-cytotoxicity as discussed in this paper. Moreover, the amount of water also played a role in peptide clustering: with a growing concentration of peptides in water without a drug, the aggregation of both Aβ(31–35) and Aβ(25–35) increased. The number of hydrogen bonds between peptides and water was significantly higher for simulations with Aβ(25–35) at the higher concentration of peptides, while for Aβ(31–35) that difference was rather insignificant. The presence of CBD did not substantially affect the number of hydrogen bonds in the simulated systems.